Advances in Amino Acid Mimetics and Peptidomimetics, Volume 2

Abell, A.

In stock
Regular price 51.750 KD inc. VAT
License
Table of contents
  • Cover
  • ADVANCES IN AMINO ACID MIMETICS AND PEPTIDOMIMETICSiii
  • Copyright Pageiv
  • Contentsv
  • LIST OF CONTRIBUTORSvii
  • PREFACExi
  • CHAPTER 1. COMBINATORIAL SYNTHESIS OF PEPTIDOMIMETICS1
  • CHAPTER 2. THE DEVELOPMENT OF NOVEL NONCOVALENT THROMBIN INHIBITORS53
  • CHAPTER 3. PEPTIDOMIMETICS DESIGNED FOR ORAL ABSORPTION89
  • CHAPTER 4. RARE PROTEIN TURNS: γ-TURN, HELIX-TURN-HELIX, AND cis-PROLINE MIMICS125
  • CHAPTER 5. DESIGN OF NON-PEPTIDE AGONISTS AND ANTAGONISTS FOR NEUROPEPTIDE RECEPTORS165
  • CHAPTER 6. AMINO ACID MIMETICS AND DESIGN OF PEPTIDOMIMETICS FOR OPIOID AND MELANOCORTIN RECEPTORS:191
  • CHAPTER 7. PEPTIDE NUCLEIC ACIDS: POTENTIAL AS ANTISENSE AND ANTIGENE DRUGS221
  • CHAPTER 8. SOLUTION AND SOLUBLE POLYMER SYNTHESES OF AZATIDES AND AZAPEPTIDES247
  • CHAPTER 9. SUGAR AMINO ACIDS AND CARBOHYDRATES AS SCAFFOLDS AND PEPTIDOMIMETICS263
  • INDEX293
Book details
  • Vendor Elsevier S & T
  • SKU 9780762306145
  • ISBN-13 9780080552637
  • Author Abell, A.
  • Category Science
  • Subject General

Do you have questions about this book?

Ask an expert!

Peptidomimetics have found wide application as bioavailable, and often potent mimetics of natural peptides. They form the basis of important classes of enzyme inhibitors, they act as receptor agonists and antagonists, and they have even been used to mimic DNA structure. Recent advances in the use of solid-phase organic synthesis have paved the way for the preparation of libraries of these structures to allow the rapid optimization of theri biological properties and hence therapeutic potential. We are also beginning to gain a greater understanding of the structural features of this class of compounds that influence their ability to permeate membranes, and their rate of clearance and metabolism. This volume brings together many of these critical issues by highlighting recent advances in a number of core peptidomimetic-based research.